Nuo Therapeutics (AURX) Gross Margin (2010 - 2026)
Nuo Therapeutics (AURX) posted Gross Margin of 66.14% for Q2 2026, down 11.10 percentage points from 77.24% a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) Gross Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Nuo Therapeutics was 65.78%, down 10.26 percentage points year-over-year; for FY2025, it was 66.94%, down 10.88 percentage points from FY2024.
- Annual Gross Margin has declined for three consecutive years, with a three-year change of -15.95 percentage points (FY2022 to FY2025).
- In prior years, Nuo Therapeutics' Gross Margin was 77.82% in FY2024 (-1.46 pp), 79.28% in FY2023 (-3.60 pp) and 82.88% in FY2022.
- Quarterly Gross Margin has run from a low of 60.59% in Q3 2025 to a high of 83.02% in Q3 2022 over five years.
- Across the past five years, year-over-year drop in Gross Margin ran from 0.57 percentage points in Q2 2024 to 15.36 percentage points in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 40.70% |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 57.71% |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 57.64% |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 67.78% |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 64.99% |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 68.27% |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 70.71% |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 46.46% |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 77.46% |
| 10 | Nuo Therapeutics | 62.45 Mn | 60.62 Mn | 1.17 Mn | 66.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.14% |
| Dec 31, 2025 | 62.76% |
| Sep 30, 2025 | 60.59% |
| Jun 30, 2025 | 77.24% |
| Mar 31, 2025 | 75.02% |
| Dec 31, 2024 | 78.12% |
| Sep 30, 2024 | 72.91% |
| Jun 30, 2024 | 82.09% |
| Mar 31, 2024 | 78.43% |
| Dec 31, 2023 | 79.00% |
| Sep 30, 2023 | 76.83% |
| Jun 30, 2023 | 82.66% |
| Mar 31, 2023 | 82.95% |
| Dec 31, 2022 | 82.81% |
| Sep 30, 2022 | 83.02% |
| Dec 31, 2019 | -258.69% |
| Sep 30, 2019 | 40.04% |
| Jun 30, 2019 | 23.85% |
| Mar 31, 2019 | 26.84% |
| Dec 31, 2018 | 96.19% |
API Access
Nuo Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();